デフォルト表紙
市場調査レポート
商品コード
1402029

代理出産市場の2030年までの予測:タイプ別、年齢層別、技術別、エンドユーザー別、地域別の世界分析

Surrogacy Market Forecasts to 2030 - Global Analysis By Type, Age Group, Technology, End User and by Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
代理出産市場の2030年までの予測:タイプ別、年齢層別、技術別、エンドユーザー別、地域別の世界分析
出版日: 2023年12月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の代理出産市場は2023年に2億1,034万米ドルを占め、2030年には3億6,282万米ドルに達すると予測され、予測期間中のCAGRは8.1%です。

代理出産と呼ばれる生殖医療では、代理出産女性が他人や夫婦に代わって子供を産み、出産します。通常の妊娠が医学的条件によって困難または不可能な場合、この生殖補助技術が利用されます。また、代理出産の主な形態としては、体外受精(IVF)により受精した胚を代理母が妊娠させる妊娠代理出産と、代理母が卵子を提供する伝統的代理出産の2つがあります。

世界保健機関(WHO)の報告によると、発展途上国では4組に1組のカップルが不妊を経験しています。また、世界では毎年6,000万から8,000万組のカップルが不妊に悩んでおり、インドだけでも1,500万から2,000万組(25%)が不妊に悩んでいます。

意識向上と受容

社会における不妊の問題に対する認識と率直な会話の増加は、代理出産が合法的で思いやりのある生殖の選択肢として受け入れられるようになってきています。さらに、擁護団体、インターネットフォーラム、教育プログラムは、代理出産にまつわる汚名を払拭し、不妊に悩む独身者やカップルにとってより励みになる雰囲気を作り出すのに役立っています。

代理出産の数は限られている

代理出産市場は、意欲的で適切な代理出産者の不足により、大きな制約を受けています。医学的、心理学的な条件を満たす適切な候補者を見つけることが困難な場合、意図する両親と代理出産をマッチングするプロセスが遅れることがあります。さらに、社会的な偏見、潜在的な健康被害に対する心配、代理出産の手順の厳しさなどが、このような不足の原因となっている可能性があります。

生殖医療における技術の進歩

遺伝子検査、胚スクリーニング、人工生殖技術の進歩など、生殖医療における継続的な技術進歩の結果として、代理出産市場には大きな機会が存在します。さらに、代理出産を希望する両親にとって、成功率の向上、胚選択の改善、より高度な不妊治療の開発により、代理出産はより現実的で費用対効果の高い選択肢となりつつあります。

規制の変化と法的不確実性

様々な管轄区域における代理出産に関する多様な法的枠組みは、代理出産業界に深刻なリスクをもたらしています。さらに、法律の迅速な変更や法的あいまいさは、代理出産団体、意中の両親、代理出産者に困難をもたらし、代理出産契約の秩序ある推進を妨げる可能性のある法的対立や合併症を引き起こす可能性があります。

COVID-19の影響:

COVID-19の流行は代理出産市場に大きな影響を与え、生殖補助医療分野に困難と混乱をもたらしました。パンデミックによってもたらされた渡航制限や閉鎖は、代理出産プロセスに参加する意中の両親、代理出産者、ヘルスケア提供者の国際的な移動を妨げています。継続的な健康上の懸念、クリニックの閉鎖、不妊治療の遅れにより、代理出産の手続きは一時的に減少しました。さらに、パンデミックの経済への影響は、代理出産サービスを受ける両親の能力に影響を与える可能性があります。

予測期間中、妊娠代理出産分野が最大となる見込み

生殖補助医療の中で最も一般的で好まれている方法として、妊娠代理出産が市場で最大のシェアを占めています。妊娠代理出産では、卵子と精子がドナーまたは妊娠を希望する両親から提供され、体外受精(IVF)によって胚が作られます。この方法は、代理出産者と子供の間の遺伝的なつながりを断ち切ることで、より感情的で法的な明確さをもたらします。さらに、生殖技術の進歩により、妊娠代理出産はより管理され予測可能なプロセスとして広く認知されるようになった。

不妊治療クリニック部門は予測期間中最も高いCAGRが見込まれます。

代理出産市場において、CAGRが最も高いセグメントは不妊治療クリニックです。最先端の生殖サービスを提供するこれらの専門クリニックは、増加する不妊症の発生率に取り組む上で不可欠です。不妊治療専門クリニックは、徹底した診断評価、体外受精(IVF)を含む最先端の生殖補助医療(ART)、患者やカップルそれぞれのニーズに合わせた個別の治療プログラムを提供しています。さらに、ARTに対する社会的受容の高まりと不妊問題に対する意識の高まりにより、不妊治療クリニックが提供するサービスへの需要が増加しています。

最大のシェアを占める地域

世界の代理出産市場では、北米が最大のシェアを占めています。洗練されたヘルスケアシステム、高い認知度、生殖技術への大規模な投資により、米国とカナダを含むこの地域が優位を占めています。不妊治療サービスの需要が高いのは、生殖補助医療(ART)が文化的に受け入れられていることや、不妊症の問題が蔓延していることも一因です。さらに、生殖医療業界における北米の主要プレイヤーとしての地位は、この地域に不妊治療分野の主要クリニック、研究機関、技術開発が集中していることによってさらに強固なものとなっています。

CAGRが最も高い地域:

代理出産の世界市場において、アジア太平洋地域のCAGRは最も高いです。アジア太平洋地域における生殖医療サービスの需要は、不妊症の有病率の上昇、生殖補助医療技術(ART)への理解と受容の高まりによって牽引されています。同地域の急成長は、ライフスタイルの進化、家族計画の先送り、リプロダクティブ・ヘルス(生殖に関する健康)の改善など、多くの要因によるものです。さらに、アジア太平洋諸国における不妊治療の拡大やヘルスケアインフラの充実が市場の成長を支えています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 技術分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の代理出産市場:タイプ別

  • 妊娠代理出産
  • 従来の代理出産
  • その他のタイプ

第6章 世界の代理出産市場:年齢層別

  • 35歳未満
  • 35~37歳
  • 38~39歳
  • 40~42歳
  • 43~44歳
  • 44歳超

第7章 世界の代理出産市場:技術別

  • 子宮内授精(IUI)
  • 体外受精(IVF)
    • クラシック/スタンダード体外受精
    • 細胞質内精子注入(ICSI)
  • その他の技術

第8章 世界の代理出産市場:エンドユーザー別

  • 病院
  • 不妊クリニック
  • その他のエンドユーザー

第9章 世界の代理出産市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第10章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第11章 企業プロファイル

  • Extraordinary Conceptions
  • Boston IVF
  • Growing Generations LLC
  • IVIRMA Global
  • Max Healthcare
  • New Hope Fertility Center
  • Bourn Hall International
  • Houston Fertility Center
  • Circle Surrogacy & Egg Donation
  • Nova Ivi Fertility
  • Ovation Fertility
  • Scanfert Clinic
  • Care Fertility Group
図表

List of Tables

  • Table 1 Global Surrogacy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 4 Global Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 5 Global Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 7 Global Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 8 Global Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 9 Global Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 10 Global Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 11 Global Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 12 Global Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 13 Global Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 14 Global Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 15 Global Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 16 Global Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 17 Global Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 18 Global Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 19 Global Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 22 Global Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 26 North America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 27 North America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 28 North America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 29 North America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 30 North America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 31 North America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 32 North America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 33 North America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 34 North America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 35 North America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 36 North America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 37 North America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 38 North America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 39 North America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 40 North America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 41 North America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 44 North America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 48 Europe Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 49 Europe Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 50 Europe Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 51 Europe Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 52 Europe Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 53 Europe Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 54 Europe Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 55 Europe Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 56 Europe Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 57 Europe Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 58 Europe Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 59 Europe Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 60 Europe Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 61 Europe Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 62 Europe Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 63 Europe Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 66 Europe Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 70 Asia Pacific Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 71 Asia Pacific Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 72 Asia Pacific Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 73 Asia Pacific Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 74 Asia Pacific Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 75 Asia Pacific Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 76 Asia Pacific Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 77 Asia Pacific Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 78 Asia Pacific Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 79 Asia Pacific Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 80 Asia Pacific Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 81 Asia Pacific Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 82 Asia Pacific Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 83 Asia Pacific Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 84 Asia Pacific Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 85 Asia Pacific Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 88 Asia Pacific Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 92 South America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 93 South America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 94 South America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 95 South America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 96 South America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 97 South America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 98 South America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 99 South America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 100 South America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 101 South America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 102 South America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 103 South America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 104 South America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 105 South America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 106 South America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 107 South America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 110 South America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 114 Middle East & Africa Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 115 Middle East & Africa Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 116 Middle East & Africa Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 117 Middle East & Africa Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 118 Middle East & Africa Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 119 Middle East & Africa Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 120 Middle East & Africa Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 121 Middle East & Africa Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 122 Middle East & Africa Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 123 Middle East & Africa Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 124 Middle East & Africa Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 126 Middle East & Africa Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 127 Middle East & Africa Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 128 Middle East & Africa Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 132 Middle East & Africa Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC24549

According to Stratistics MRC, the Global Surrogacy Market is accounted for $210.34 million in 2023 and is expected to reach $362.82 million by 2030 growing at a CAGR of 8.1% during the forecast period. A surrogate woman bears and gives birth to a child on behalf of another person or couple in a reproductive arrangement known as surrogacy. When conventional conception is difficult or impossible due to medical conditions, this assisted reproductive technology is used. Moreover, the two main forms of surrogacy are gestational surrogacy, in which the surrogate carries an embryo fertilized by in vitro fertilization (IVF), usually using the genetic material of the intended parents or donors, and traditional surrogacy, in which the surrogate contributes her egg.

According to a report by the World Health Organization (WHO), one in four couples in developing nation's experiences infertility. Additionally, 60-80 million couples worldwide suffer from infertility each year, with 15-20 million (25%) residing in India alone.

Market Dynamics:

Driver:

Raising awareness and acceptance

Growing awareness campaigns and a more candid conversation about fertility issues in society are supporting surrogacy's growing acceptance as a legal and compassionate reproductive option. Additionally, advocacy groups, internet forums, and educational programs help dispel the stigmas surrounding surrogacy and create a more encouraging atmosphere for single people and couples dealing with infertility.

Restraint:

Limited number of surrogates available

The surrogacy market is significantly constrained by the lack of willing and suitable surrogates. The process of matching intended parents with surrogates can be delayed when appropriate candidates who fulfill both medical and psychological requirements are difficult to find. Furthermore, social stigmas, worries about potential health hazards, or the rigorous requirements of the surrogacy procedure could all contribute to this shortage.

Opportunity:

Technological progress in reproductive health

Significant opportunities exist for the surrogacy market as a result of ongoing technological advancements in reproductive medicine, such as advances in genetic testing, embryo screening, and artificial reproductive techniques. Moreover, for intended parents, surrogacy is becoming a more practical and cost-effective option thanks to increased success rates, improved embryo selection, and the development of more advanced fertility treatments.

Threat:

Regulation changes and legal uncertainties

Diverse legal frameworks for surrogacy across different jurisdictions present a serious risk to the surrogacy industry. Additionally, swift alterations in laws or legal ambiguities could pose difficulties for surrogacy organizations, intended parents, and surrogates, resulting in possible legal conflicts and complications that could hinder the orderly advancement of surrogacy agreements.

COVID-19 Impact:

The COVID-19 pandemic has had a major effect on the surrogacy market and brought difficulties and disturbances to the assisted reproductive sector. Travel restrictions and lockdowns brought on by the pandemic have hindered the international mobility of intended parents, surrogates, and healthcare providers participating in the surrogacy process. There has been a brief decrease in surrogacy procedures due to ongoing health concerns, clinic closures, and delays in fertility treatments. Furthermore, the pandemic's effects on the economy could have an impact on intended parents' ability to afford surrogacy services.

The Gestational Surrogacy segment is expected to be the largest during the forecast period

As the most common and favored method of assisted reproduction, gestational surrogacy commands the largest share of the market. When a person is used in a gestational surrogacy, their eggs and sperm from donors or the intended parents are used to create an embryo through in vitro fertilization (IVF). This approach provides more emotional and legal clarity by severing genetic ties between the surrogate and the child. Moreover, reproductive technology advancements have made gestational surrogacy more widely recognized as a more controlled and predictable process.

The Fertility Clinics segment is expected to have the highest CAGR during the forecast period

In the surrogacy market, the segment with the highest CAGR is fertility clinics. These specialist clinics, which provide a range of cutting-edge reproductive services, are essential in tackling the growing incidence of infertility. Fertility clinics offer thorough diagnostic evaluations, state-of-the-art assisted reproductive technologies (ART), including in vitro fertilization (IVF), and individualized treatment programs made to meet each patient's or couple's specific needs. Additionally, the demand for the services provided by fertility clinics has increased due to rising societal acceptance of ART and increased awareness of fertility issues.

Region with largest share:

In the global surrogacy market, North America holds the largest share. Because of its sophisticated healthcare system, high level of awareness, and large investments in reproductive technologies, this region-which includes the United States and Canada-dominates. The high demand for fertility services is partly due to the cultural acceptance of assisted reproductive technologies (ART) and the prevalence of infertility problems. Moreover, North America's status as a major player in the reproductive healthcare industry is further cemented by the region's concentration of top fertility clinics, research institutes, and technological developments in the field.

Region with highest CAGR:

In terms of the global market for surrogacy, the Asia-Pacific region has the highest CAGR. The demand for reproductive services in Asia-Pacific is driven by the rising prevalence of infertility as well as increased understanding and acceptance of assisted reproductive technologies (ART). The region's rapid growth is caused by a number of factors, including evolving lifestyles, postponing family planning, and improvements in reproductive health. Furthermore, expanding fertility treatments and better healthcare infrastructure in Asia-Pacific nations support the market's growth.

Key players in the market:

Some of the key players in Surrogacy market include Extraordinary Conceptions, Boston IVF, Growing Generations LLC, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Bourn Hall International, Houston Fertility Center, Circle Surrogacy & Egg Donation, Nova Ivi Fertility, Ovation Fertility, Scanfert Clinic and Care Fertility Group.

Key Developments:

In November 2023, IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company's commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.

In October 2023, Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.

Types Covered:

  • Gestational Surrogacy
  • Traditional Surrogacy
  • Other Types

Age Groups Covered:

  • Below 35 Years
  • 35-37 Years
  • 38-39 Years
  • 40-42 Years
  • 43-44 Years
  • Over 44 Years

Technologies Covered:

  • Intrauterine Insemination (IUI)
  • In-vitro Fertilization (IVF)
  • Other Technologies

End Users Covered:

  • Hospitals
  • Fertility Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Surrogacy Market, By Type

  • 5.1 Introduction
  • 5.2 Gestational Surrogacy
  • 5.3 Traditional Surrogacy
  • 5.4 Other Types

6 Global Surrogacy Market, By Age Group

  • 6.1 Introduction
  • 6.2 Below 35 Years
  • 6.3 35-37 Years
  • 6.4 38-39 Years
  • 6.5 40-42 Years
  • 6.6 43-44 Years
  • 6.7 Over 44 Years

7 Global Surrogacy Market, By Technology

  • 7.1 Introduction
  • 7.2 Intrauterine Insemination (IUI)
  • 7.3 In-vitro Fertilization (IVF)
    • 7.3.1 Classical/Standard IVF
    • 7.3.2 Intracytoplasmic Sperm Injection (ICSI)
  • 7.4 Other Technologies

8 Global Surrogacy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Fertility Clinics
  • 8.4 Other End Users

9 Global Surrogacy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Extraordinary Conceptions
  • 11.2 Boston IVF
  • 11.3 Growing Generations LLC
  • 11.4 IVIRMA Global
  • 11.5 Max Healthcare
  • 11.6 New Hope Fertility Center
  • 11.7 Bourn Hall International
  • 11.8 Houston Fertility Center
  • 11.9 Circle Surrogacy & Egg Donation
  • 11.10 Nova Ivi Fertility
  • 11.11 Ovation Fertility
  • 11.12 Scanfert Clinic
  • 11.13 Care Fertility Group